Latest debt-to-equity ratio
Axsome Therapeutics Debt-to-equity ratio
Direct answer
Axsome Therapeutics's debt-to-equity ratio is 269.73%.
The verified market snapshot reports 269.73%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 269.73%
Explore related company data
View Axsome Therapeutics's market capitalizationView Axsome Therapeutics's price-to-book ratioView Axsome Therapeutics's return on equityView Axsome Therapeutics's dividend yieldView Axsome Therapeutics's 52-week price rangeView Axsome Therapeutics's revenue growthView Axsome Therapeutics's profit marginView all Axsome Therapeutics key metricsReturn to Axsome Therapeutics profile